Swipe tables sideways to see all columns.
Research findings
Cohort structure analysis
Recorded industry counts in this 26-record cohort: Biomedicine (14 records); Next-generation information technology (4 records).
The record-count gap between Biomedicine and Next-generation information technology is 10, or 38.5% of this 26-record base. The gap concerns records, not revenue or market position.
| Company cohort | Directly linked pages | Share of public archive | Archive date |
|---|---|---|---|
| 26 | 26 | 0.1% | 2026-10-16 |
Deduplicated company IDs.
Counts within parent sets
| Set | All records | This subset | Excluding this subset |
|---|---|---|---|
| All public archive records | 19,297 | 26 | 19,271 |
Observed labels
| Dimension | Label | Count/base | Participation |
|---|---|---|---|
| industry | Biomedicine | 14/26 | 53.8% |
| industry | Next-generation information technology | 4/26 | 15.4% |
| industry | New energy and power equipment | 2/26 | 7.7% |
| industry | Advanced equipment | 2/26 | 7.7% |
| industry | Advanced materials | 1/26 | 3.8% |
| chain role | Biomedicine and medical devices / Complete systems and use-case applications | 13/26 | 50.0% |
| chain role | Electronic information and digital technology / Digital software and industrial services | 4/26 | 15.4% |
| chain role | Electronic information and digital technology / Core components and digital hardware | 2/26 | 7.7% |
| chain role | Construction materials and infrastructure / Complete systems and use-case applications | 1/26 | 3.8% |
| chain role | Advanced materials / Basic and process materials | 1/26 | 3.8% |
Multi-label counts can overlap; filter compliance is not industrial advantage.
Evidence and list-linkage counts
| Measure | Count |
|---|---|
| Companies with existing sourced excerpts | 15/26 |
| Existing reviewed bilingual excerpt pairs | 15 |
| IDs linked to 2026 local lists | 3/26 |
| Product-field rule reminders | 1/26 |
Existing excerpts do not certify entire old reports; list linkage is not final recognition. Full definitions are on the series page.
Provincial context and cohort interpretation
The provincial macro sources below use a different denominator from this 26-record archive cohort; they do not establish individual operating results.
Which activities belong in the same comparison when high-technology manufacturing, oil-gas extraction and pharmaceuticals diverge?
In 2025, Hainan’s high-tech manufacturing above designated size grew by 28.1% in value added. Among its principal industrial sectors, oil and gas extraction grew by 48.7%, while pharmaceutical manufacturing fell by 12.2%. Free-trade-port policies should not be presented as already-realised operating benefits for every manufacturer. [1]
Interpretation and test conditions
Hainan recorded growth in high-technology manufacturing and oil-gas extraction value added in 2025, while pharmaceutical manufacturing declined. Extraction is a mining activity. Separate activity types before comparing firms' product and service roles, rather than treating the figures as a shared manufacturing expansion. [1]
A pharmaceutical decline can coexist with high-technology manufacturing growth because the measures do not describe the same firm or product set. Distinguish drugs, devices, research services and other technology products, then check source coverage. The macro figures do not determine technical quality or registration progress. [1]
Compare deliverables for extraction suppliers and manufacturers. For records claiming policy benefits, inspect eligibility and implementation documents. Free-trade-port policy provides institutional context; each firm needs evidence of any realised cost or customs benefit. [1]
Recorded roles and delivery checks
Related studies and shared records
| Comparison study | Reference records | Shared IDs | Focal only | Intersection/union |
|---|---|---|---|---|
| Food Freeze Drying Vacuum Drying Equipment Keyword Candidate Study | 8 | 1 | 25 | 3.0% |
| Agricultural Biotech Seed Industry Keyword Candidate Study | 10 | 1 | 25 | 2.9% |
Company samples and record links
| Company | Jurisdiction | Recorded industry |
|---|---|---|
| Hainan Brilliant Pharmaceutical Co., Ltd. | Hainan | Biomedicine |
| Hainan Baotong Industry Company. | Hainan | Advanced equipment |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | Hainan | Biomedicine |
| Hainan Flyer Technology Co., Ltd. | Hainan | Advanced equipment |
| Hainan Zhengye Biotechnology Co., Ltd. | Hainan | Biomedicine |
| Hainan Simcere Pharmaceutical Co., Ltd. | Hainan | Biomedicine |
| Hainan Tianhong Municipal Design Co., Ltd. | Hainan | Producer services |
| Hainan Jinyu Medical Testing Center Co., Ltd. | Hainan | Biomedicine |
Directly related profiles and reports
| Page | Presentation |
|---|---|
| Hainan Brilliant Pharmaceutical Co., Ltd. | Company data profile |
| Hainan Baotong Industry Company. | Company data profile |
| Hainan Huluwa Pharmaceutical Group Co., Ltd. | Company data profile |
| Hainan Flyer Technology Co., Ltd. | Company data profile |
| Hainan Zhengye Biotechnology Co., Ltd. | Company data profile |
| Hainan Simcere Pharmaceutical Co., Ltd. | Company data profile |